Interestingly, we identified for the first time to found statistically elevated levels of the proinflammatory cytokine, IL-6, and oxidative stress markers, ADMA, in patients with PAD compared to that in non-PAD controls, demonstrating that there is a characteristic pattern of phlogistic biomarkers in subjects with PAD. Here, IL6 is linked to peripheral arterial disease.